Please Wait.....
Report
Brazil Point-of-Care Glucose Testing Market By Product Type (Lancing Devices and Strips, Blood-Glucose Meter), By Application (Type-1 Diabetes, Type-2 Diabetes), By End User (Hospitals and Clinics, Home Care Settings, Others): Opportunity Analysis and Industry Forecast, 2023-2032
Market Report I 2023-11-01 I 85 Pages I Allied Market Research
The Brazil point-of-care glucose testing market is anticipated to witness steady growth during the forecast period.The major factors driving the growth of the market is due to the increase in the prevalence of diabetes where both type-1 and type-2 diabetes have reached alarming proportions. In addition, the need for real-time glucose monitoring with the surge in the demand for point-of-care glucose testing devices contribute toward the growth of the market.The Brazil point-of-care glucose testing market is segmented into product type, application, and end user. On the basis of product type, the market is classified into lancing devices & strips and blood glucose meters. By application, the market is divided into type 1 diabetes and type 2 diabetes. Depending on the end user, the market segregated into hospitals and clinics, home care settings, and others.However, stringent government regulations pertaining to complex regulatory tasks restrict the growth of the market.
The Brazil point-of-care glucose testing market is anticipated to offer several opportunities and future trends for new players in the market. One of the future trends witness in the market is rise in trend in the integration of technology toward an era of digital healthcare, leading to the surge in smart glucose monitoring solutions which provides real-time glucose and facilitate data sharing with healthcare professionals and cloud-based platforms. In addition, the government initiatives to promote greater accessibility to healthcare services resulting in the increased adoption of point-of-care testing devices, especially in underprivileged regions, is expected to offer remunerative opportunities for the growth of the market.Moreover, stringent government regulations pertaining to quality control measures, certification requirements, and data security regulations offer new avenues for the growth of the market.
The major players in the Brazil point-of-care glucose testing market are focusing on various strategies to gain a competitive advantage over market competitors. They use strategies such as acquisition, financial strategy, market development, product development & innovation strategy, diversification, marketing strategy, go-to-market strategy, digital strategy, consumer strategy, segmentation strategy, promotion strategy, and channel strategy to gain a competitive advantage. Furthermore, mergers & acquisitions and new product launches are important techniques employed by market leaders to enhance their market dominance.
The Porter's five forces analysis is a model, which analyzes the competitive scenario of the industry and role of each stakeholder. The five forces include the bargaining power of buyers, the bargaining power of suppliers, the threat of new entrants, the threat of substitutes, and the level of competitive rivalry. The bargaining power of suppliers offers suppliers a degree of power, particularly those who specialize in unique components or technologies. Suppliers can hold the sway by delivering high-quality, innovative products demanded by the market. The bargaining power of buyers, including hospitals, clinics, and home care settings, wield significant power due to their diversity. The intricacies lie in catering to the varying demands of these buyers and aligning products accordingly. The threat of the new entrants due to the complexity of regulations and the need for substantial investment in R&D create high entry barriers in this market. The threat of the substitutes in the market is not immune to the threat of substitutes, as advancements in non-invasive glucose monitoring technologies could potentially disrupt the industry's dynamics. The dynamics. The level of competitive rivalry is intricate, with established players vying for market share. Price wars, innovation, and branding strategies are essential to survive and thrive in this fiercely competitive domain.
A SWOT analysis provides an overview of the Brazil point-of-care glucose testing market. It includes its internal strength, weakness, opportunities and threats. The strength of the market includes strong growth potential, driven by rise in prevalence of diabetes and the increase in the adoption of point-of-care testing. The robust R&D activities and technological advancements enhance the market's potential for innovation. The weaknesses include regulatory hurdles, complex reimbursement processes, and the need for significant investment in R&D pose significant challenges. The market's fragmented nature adds a layer of complexity. The opportunities include the home care settings sector, the integration of technology, and Brazil's push for universal healthcare coverage present several opportunities for market growth. Tailoring products to meet consumer preferences can further amplify these opportunities. The threat includes multifaceted, encompassing regulatory barriers, potential disruptive technologies, and fierce market competition. Economic fluctuations and cost pressures add to the complex challenges faced by market players.
Several new companies are identified as emerging in the market, such asAbbott,Ascensia Diabetes Care,Roche,LifeScan,Medtronic,Terumo Corporation,Bayer AG,Arkray,Accu-Chek, andTrividia Health.
Key Benefits For Stakeholders
Enable informed decision-making process and offer market analysis based on current market situation and estimated future trends.
Analyze the key strategies adopted by major market players in Brazil point-of-care glucose testing market.
Assess and rank the top factors that are expected to affect the growth of Brazil point-of-care glucose testing market.
Top Player positioning provides a clear understanding of the present position of market players.
Detailed analysis of the Brazil point-of-care glucose testing market segmentation assists to determine the prevailing market opportunities.
Identify key investment pockets for various offerings in the market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Product Benchmarking / Product specification and applications
- Upcoming/New Entrant by Regions
- New Product Development/ Product Matrix of Key Players
- Patient/epidemiology data at country, region, global level
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- SWOT Analysis
Key Market Segments
By Product Type
- Lancing Devices and Strips
- Blood-Glucose Meter
- Type
- Lifescan OneTouch Ultra and Lifescan OneTouch Verio
- Accu-Chek Aviva Plus and Accuchek
- Freestyle Lite and Freestyle Precission Neo
- Contour Next
- Others
By Application
- Type-1 Diabetes
- Type-2 Diabetes
By End User
- Hospitals and Clinics
- Home Care Settings
- Others
- Key Market Players
- Abbott
- Ascensia Diabetes Care
- Roche
- LifeScan
- Medtronic
- Terumo Corporation
- Bayer AG
- Arkray
- Accu-Chek
- Trividia Health
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits to the Stakeholders
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Impacting Factors
3.2.2. Top Investment Pockets
3.3. Porter's Five Forces Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market Size and Forecast, By Product Type
4.2. Lancing Devices and Strips
4.3. Blood-Glucose Meter
CHAPTER 5: BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market Size and Forecast, By Application
5.2. Type-1 Diabetes
5.3. Type-2 Diabetes
CHAPTER 6: BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER
6.1. Overview
6.1.1. Market Size and Forecast, By End User
6.2. Hospitals and Clinics
6.3. Home Care Settings
6.4. Others
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2022
CHAPTER 8: COMPANY PROFILES
8.1. Abbott
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. Ascensia Diabetes Care
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.2.7. Key strategic moves and developments
8.3. Roche
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.3.7. Key strategic moves and developments
8.4. LifeScan
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.4.7. Key strategic moves and developments
8.5. Medtronic
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.5.7. Key strategic moves and developments
8.6. Terumo Corporation
8.6.1. Company overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.6.6. Business performance
8.6.7. Key strategic moves and developments
8.7. Bayer AG
8.7.1. Company overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business performance
8.7.7. Key strategic moves and developments
8.8. Arkray
8.8.1. Company overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.8.6. Business performance
8.8.7. Key strategic moves and developments
8.9. Accu-Chek
8.9.1. Company overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Business performance
8.9.7. Key strategic moves and developments
8.10. Trividia Health
8.10.1. Company overview
8.10.2. Key Executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
8.10.6. Business performance
8.10.7. Key strategic moves and developments
LIST OF TABLES
TABLE 01. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 02. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 03. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 04. ABBOTT: KEY EXECUTIVES
TABLE 05. ABBOTT: COMPANY SNAPSHOT
TABLE 06. ABBOTT: OPERATING SEGMENTS
TABLE 07. ABBOTT: PRODUCT PORTFOLIO
TABLE 08. ABBOTT: KEY STRATERGIES
TABLE 09. ASCENSIA DIABETES CARE: KEY EXECUTIVES
TABLE 10. ASCENSIA DIABETES CARE: COMPANY SNAPSHOT
TABLE 11. ASCENSIA DIABETES CARE: OPERATING SEGMENTS
TABLE 12. ASCENSIA DIABETES CARE: PRODUCT PORTFOLIO
TABLE 13. ASCENSIA DIABETES CARE: KEY STRATERGIES
TABLE 14. ROCHE: KEY EXECUTIVES
TABLE 15. ROCHE: COMPANY SNAPSHOT
TABLE 16. ROCHE: OPERATING SEGMENTS
TABLE 17. ROCHE: PRODUCT PORTFOLIO
TABLE 18. ROCHE: KEY STRATERGIES
TABLE 19. LIFESCAN: KEY EXECUTIVES
TABLE 20. LIFESCAN: COMPANY SNAPSHOT
TABLE 21. LIFESCAN: OPERATING SEGMENTS
TABLE 22. LIFESCAN: PRODUCT PORTFOLIO
TABLE 23. LIFESCAN: KEY STRATERGIES
TABLE 24. MEDTRONIC: KEY EXECUTIVES
TABLE 25. MEDTRONIC: COMPANY SNAPSHOT
TABLE 26. MEDTRONIC: OPERATING SEGMENTS
TABLE 27. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 28. MEDTRONIC: KEY STRATERGIES
TABLE 29. TERUMO CORPORATION: KEY EXECUTIVES
TABLE 30. TERUMO CORPORATION: COMPANY SNAPSHOT
TABLE 31. TERUMO CORPORATION: OPERATING SEGMENTS
TABLE 32. TERUMO CORPORATION: PRODUCT PORTFOLIO
TABLE 33. TERUMO CORPORATION: KEY STRATERGIES
TABLE 34. BAYER AG: KEY EXECUTIVES
TABLE 35. BAYER AG: COMPANY SNAPSHOT
TABLE 36. BAYER AG: OPERATING SEGMENTS
TABLE 37. BAYER AG: PRODUCT PORTFOLIO
TABLE 38. BAYER AG: KEY STRATERGIES
TABLE 39. ARKRAY: KEY EXECUTIVES
TABLE 40. ARKRAY: COMPANY SNAPSHOT
TABLE 41. ARKRAY: OPERATING SEGMENTS
TABLE 42. ARKRAY: PRODUCT PORTFOLIO
TABLE 43. ARKRAY: KEY STRATERGIES
TABLE 44. ACCU-CHEK: KEY EXECUTIVES
TABLE 45. ACCU-CHEK: COMPANY SNAPSHOT
TABLE 46. ACCU-CHEK: OPERATING SEGMENTS
TABLE 47. ACCU-CHEK: PRODUCT PORTFOLIO
TABLE 48. ACCU-CHEK: KEY STRATERGIES
TABLE 49. TRIVIDIA HEALTH: KEY EXECUTIVES
TABLE 50. TRIVIDIA HEALTH: COMPANY SNAPSHOT
TABLE 51. TRIVIDIA HEALTH: OPERATING SEGMENTS
TABLE 52. TRIVIDIA HEALTH: PRODUCT PORTFOLIO
TABLE 53. TRIVIDIA HEALTH: KEY STRATERGIES
LIST OF FIGURES
FIGURE 01. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET (2023-2032)
FIGURE 04. PORTER FIVE-1
FIGURE 05. PORTER FIVE-2
FIGURE 06. PORTER FIVE-3
FIGURE 07. PORTER FIVE-4
FIGURE 08. PORTER FIVE-5
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET
FIGURE 10. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET,BY PRODUCT TYPE, 2022 ($MILLION)
FIGURE 11. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET,BY APPLICATION, 2022 ($MILLION)
FIGURE 12. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET,BY END USER, 2022 ($MILLION)
FIGURE 13. TOP WINNING STRATEGIES, BY YEAR
FIGURE 14. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 15. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 16. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 17. COMPETITIVE DASHBOARD
FIGURE 18. COMPETITIVE HEATMAP: BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET
FIGURE 19. TOP PLAYER POSITIONING, 2022
FIGURE 20. ABBOTT: NET SALES, 2020-2022*($MILLION)
FIGURE 21. ABBOTT: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 22. ABBOTT: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 23. ASCENSIA DIABETES CARE: NET SALES, 2020-2022*($MILLION)
FIGURE 24. ASCENSIA DIABETES CARE: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 25. ASCENSIA DIABETES CARE: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 26. ROCHE: NET SALES, 2020-2022*($MILLION)
FIGURE 27. ROCHE: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 28. ROCHE: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 29. LIFESCAN: NET SALES, 2020-2022*($MILLION)
FIGURE 30. LIFESCAN: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 31. LIFESCAN: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 32. MEDTRONIC: NET SALES, 2020-2022*($MILLION)
FIGURE 33. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 34. MEDTRONIC: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 35. TERUMO CORPORATION: NET SALES, 2020-2022*($MILLION)
FIGURE 36. TERUMO CORPORATION: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 37. TERUMO CORPORATION: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 38. BAYER AG: NET SALES, 2020-2022*($MILLION)
FIGURE 39. BAYER AG: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 40. BAYER AG: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 41. ARKRAY: NET SALES, 2020-2022*($MILLION)
FIGURE 42. ARKRAY: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 43. ARKRAY: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 44. ACCU-CHEK: NET SALES, 2020-2022*($MILLION)
FIGURE 45. ACCU-CHEK: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 46. ACCU-CHEK: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 47. TRIVIDIA HEALTH: NET SALES, 2020-2022*($MILLION)
FIGURE 48. TRIVIDIA HEALTH: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 49. TRIVIDIA HEALTH: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security